The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Nitric oxide released from activated platelets inhibits platelet recruitment.
Open accessAbstract
Vessel injury and thrombus formation are the cause of most ischemic coronary syndromes and, in this setting, activated platelets stimulate platelet recruitment to the growing thrombus. Recently, a constitutive nitric oxide synthase (NOS) has been identified in human platelets. To further define the capacity of platelets to produce nitric oxide (NO), as well as to study the role of this NO in platelet recruitment, we adapted a NO-selective microelectrode for use in a standard platelet aggregometer, thereby permitting simultaneous measurement of platelet aggregation and NO production. Treatment of platelets with the NO synthase inhibitor -NG-nitroarginine methyl ester (L-NAME), reduced NO production by 92+/-8% in response to 5 microM ADP compared to control but increased aggregation by only 15+/-2%. In contrast, L-NAME had a more pronounced effect on platelet recruitment as evidenced by a 35+/-5% increase in the extent of aggregation, a 33+/-3% decrease in cyclic GMP content, and a 31+/-5% increase in serotonin release from a second recruitable population of platelets added to stimulated platelets at the peak of NO production. To study platelet recruitment accurately, we developed an assay that monitors two platelet populations simultaneously. Nonbiotinylated platelets were incubated with L-NAME or vehicle and activated with ADP. At peak NO production, biotinylated platelets were added. As measured by three-color flow cytometry, there was a 56+/-11% increase in the number of P selectin- positive platelets in the nonbiotinylated population treated with L-NAME as compared to control. When biotinylated platelets were added to the L-NAME-treated nonbiotinylated population, the number of P selectin positive biotinylated plate-lets increased by 180+/-32% as compared to biotinylated platelets added to the control. In summary, stimulated platelets produce NO that modestly inhibits platelet activation but markedly inhibits additional platelet recruitment. These data suggest that platelet-derived NO may regulate platelet recruitment to a growing thrombus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
DeWood, M. A., Spores, J., Notske, R., Mouser, L. T., Burroughs, R., Golden, M. S., & Lang, H. T. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031601 · Cited by 2,740
The aggregation of blood platelets
Born, G. V. R., & Cross, M. J. (1963) · The Journal of Physiology · doi:10.1113/jphysiol.1963.sp007185 · Cited by 2,111
Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
Davies, M. J., & Thomas, A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101801 · Cited by 1,694
Little, W. C., Constantinescu, M., Applegate, R. J., Kutcher, M. A., Burrows, M. T., Kahl, F. R., & Santamore, W. P. (1988) · Circulation · doi:10.1161/01.cir.78.5.1157 · Cited by 1,474
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski, M. W., Palmer, R. M., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5193 · Cited by 1,208
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,173
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y.-M., Sajer, S. A., & Furie, B. (1992) · Nature · doi:10.1038/359848a0 · Cited by 808
Mellion, B., Ignarro, L., Ohlstein, E., Pontecorvo, E., Hyman, A., & Kadowitz, P. (1981) · Blood · doi:10.1182/blood.v57.5.946.946 · Cited by 639
P-selectin induces the expression of tissue factor on monocytes.
Celi, A., Pellegrini, G., Lorenzet, R., De Blasi, A., Ready, N., Furie, B. C., & Furie, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8767 · Cited by 590
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf, J. C., Banga, J. D., Moncada, S., Palmer, R. M., de Groot, P. G., & Sixma, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2284 · Cited by 337
The platelet function defect of cardiopulmonary bypass [see comments]
Kestin, A., Valeri, C., Khuri, S., Loscalzo, J., Ellis, P., MacGregor, H., Birjiniuk, V, Ouimet, H., Pasche, B., & Nelson, M. (1993) · Blood · doi:10.1182/blood.v82.1.107.bloodjournal821107 · Cited by 323
Self-citationEndogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis.
Shultz, P. J., & Raij, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116045 · Cited by 309
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol
Cooke, J. P., Stamler, J., Andon, N., Davies, P. F., McKinley, G., & Loscalzo, J. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.3.h804 · Cited by 256
Self-citationN-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
Stamler, J., Mendelsohn, M. E., Amarante, P., Smick, D., Andon, N., Davies, P. F., Cooke, J. P., & Loscalzo, J. (1989) · Circulation Research · doi:10.1161/01.res.65.3.789 · Cited by 244
Self-citationSantos, M. T., Valles, J., Marcus, A. J., Safier, L. B., Broekman, M. J., Islam, N., Ullman, H. L., Eiroa, A. M., & Aznar, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115032 · Cited by 242
Yao, S. K., Ober, J. C., Krishnaswami, A., Ferguson, J. J., Anderson, H. V., Golino, P., Buja, L. M., & Willerson, J. T. (1992) · Circulation · doi:10.1161/01.cir.86.4.1302 · Cited by 198
Direct Electrochemical Measurement of Nitric Oxide Released from Human Platelets
Malinski, T., Radomski, M. W., Taha, Z., & Moncada, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1914 · Cited by 196
Expression of constitutive endothelial nitric oxide synthase in human blood platelets
Sase, K., & Michel, T. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02191-k · Cited by 193
Hawiger, J., Parkinson, S., & Timmons, S. (1980) · Nature · doi:10.1038/283195a0 · Cited by 188
Adams, M. R., Forsyth, C. J., Jessup, W., Robinson, J., & Celermajer, D. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00257-9 · Cited by 184
Practical nitric oxide measurement employing a nitric oxide-selective electrode
Ichimori, K., Ishida, H., Fukahori, M., Nakazawa, H., & Murakami, E. (1994) · Review of Scientific Instruments · doi:10.1063/1.1144674 · Cited by 180
Broekman, M., Eiroa, A. M., & Marcus, A. (1991) · Blood · doi:10.1182/blood.v78.4.1033.1033 · Cited by 104
Effects of nitric oxide/EDRF on platelet surface glycoproteins
Michelson, A. D., Benoit, S., Furman, M. I., Breckwoldt, W. L., Rohrer, M. J., Barnard, M. R., & Loscalzo, J. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1640 · Cited by 101
Self-citationNitric oxide release from resting human platelets
Zhou, Q., Hellermann, G., & Solomonson, L. P. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)90868-g · Cited by 90
Vallés, J., Santos, M. T., Marcus, A. J., Safier, L. B., Broekman, M. J., Islam, N., ULLMAN, H. L., & Aznar, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116709 · Cited by 69
Effect of Nitric Oxide Synthase Inhibition on Bleeding Time in Humans
Simon, D. I., Stamler, J. S., Loh, E., Loscalzo, J., Francis, S. A., & Creager, M. A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00022 · Cited by 68
Self-citation
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Self-citationBenavente-García, O., & Castillo, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8006568 · Cited by 1,158
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Watson, T., Shantsila, E., & Lip, G. Y. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60040-4 · Cited by 1,123
Integrin Signaling: The Platelet Paradigm
Shattil, S. J., Kashiwagi, H., & Pampori, N. (1998) · Blood · doi:10.1182/blood.v91.8.2645.2645_2645_2657 · Cited by 665
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
Self-citation
Metadata
- Authors
- Freedman, J. E., Loscalzo, J., Barnard, M. R., Alpert, C., Keaney, J. F., & Michelson, A. D.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-07-15
- Volume
- 100
- Issue
- 2
- Pages
- 350-356
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2067057392
- Cited by
- 389
- References
- 30
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.